Lead researcher Dr. Wendy Bennett from Johns Hopkins University School of Medicine expresses a keen interest in exploring why women with diabetes face a heightened risk of heart disease compared to their male counterparts. She notes the significant role of sex hormones in potentially explaining these disparities in heart health outcomes.
This research, featured in Diabetes Care, was supported by funding from the National Institutes of Health.
Monitoring Hormone Levels
The study utilized data from the Look Ahead project, a comprehensive long-term investigation into the impact of weight loss on heart health among individuals with type 2 diabetes. Even after the primary trial concluded, participants continued to receive ongoing care, allowing researchers to gather further health data.
For this analysis, blood samples were collected from participants at the study's onset and again after one year to assess changes in hormone levels and their potential links to heart disease risk.
Distinct Hormone Patterns Observed
Dr. Bennett highlights the findings, stating, "We were able to observe how hormone changes influenced heart disease risk." In male participants, higher testosterone levels at the study's start correlated with a lower risk of heart disease, while increases in estradiol after one year were associated with a greater risk.
Conversely, among female participants, no clear connections were found between hormone levels and cardiovascular outcomes. This indicates that hormonal effects on heart disease risk may vary by sex, or that other biological and clinical factors might play a more significant role for women with diabetes.
Advancing Personalized Heart Disease Prevention
Dr. Bennett emphasizes that the study's outcomes enhance our understanding of how monitoring sex hormones in diabetic patients could supplement knowledge about traditional heart disease risk factors, such as smoking and cholesterol levels. These insights could aid clinicians in tailoring heart disease prevention strategies in the future.
Looking forward, the research team aims to investigate additional health outcomes related to hormones and diabetes. Future studies will explore the effects of weight loss and hormonal changes on bone health and identify patients at higher fracture risk. Additionally, new research will focus on hormonal declines during the menopausal transition and their influence on cardiovascular risk, particularly among those with chronic conditions like diabetes.
Study Team and Funding
The research team includes various experts, with some reporting consultancy roles unrelated to this study. Funding was provided by two National Institute of Health grants aimed at diabetes and kidney diseases.
